Sudeep Pharma Ltd share price inched up 0.10% to Rs 869.45. The Company's net profit fell 16.38% to Rs 40.59 crore, while revenue from operations reduced 13.20% to Rs 158.27 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.82 lakh crore, easing 6.18%. It has improved by 0.41% over last one week and rose by 11.45% in last one month while the market capitalization of Sudeep Pharma Ltd has softened by 1.06% and 29.50% in the same period respectively. Profit before tax (PBT) of Sudeep Pharma Ltd stood at Rs 54.29 crore in Q2 FY26, rallying 23.19% year-on-year, and dropping 13.40% quarter-on-quarter. EBITDA came in at Rs 49 crore, expanding by 27.77% YoY and falling 11.95% sequentially. Total expenses reduced by 13.16% to Rs 107.36 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 68.81 crore, slightly declining by 3.28% YoY, while employee benefits expense was at Rs 14.34 crore, witnessing a strong rise of 36.31% YoY. For the TTM ended FY26, revenue from operations witnessed a strong growth of 27.94% to Rs 642.26 crore, while net profit soared by 25.63% to Rs 174.28 crore, compared to previous TTM. EBITDA surged by 18384% to Rs 193.31 crore, and PBT surged 24.73% to Rs 228.07 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 69.55 crore in FY26, as against Rs 48.73 crore in FY25. Sudeep Pharma Ltd jumped 12.38% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 3.20% during the same period.